Secondary analyses of the TTM and TTM2 trials found no neurological injury or cerebral ischemia markers that identified out-of-hospital cardiac arrest patients who would benefit more from therapeutic hypothermia at 33°C. The analysis included 2,789 adults and showed 6-month mortality of 49.4% in the 33°C hypothermia group versus 47.9% in the normal-temperature control group. Neither causal forests nor BART detected meaningful heterogeneity in treatment effects. The analysis does not support selecting a lower temperature target solely because a patient has more severe early neurological injury, but it also cannot prove that all patients respond identically to hypothermia.
Source:HealthManagement.org · Read original article
Leave a Reply